This is unpublished

Using Biomarkers to Add Precision to Cardiovascular Medicine, Prevention and Population Health

October 20, 2023
James de Lemos, MD


Upon completion of this program, attendees should be able to:

  • Listeners will understand the limitations of currently available cardiovascular risk assessment and precision medicine tools.
  • Participants will understand the strengths and limitations of currently available biomarkers, including c-reactive protein, troponins and natriuretic peptides, for risk assessment and therapeutic guidance in cardiovascular prevention. Be familiar with current state of literature
  • The listener will be able to use actuarial risk assessment for specific cardiovascular outcomes to help  guide decisions for CVD prevention and treatment.


The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Washington School of Medicine designates this live activity for a maximum of 36.0 AMA PRA Category 1 Credits.

Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 1.0 credit)

To request disability accommodation, contact the Office of the Disability Services Office at least ten days in advance of the event at 206-543-6450 (voice), 206-543-6452 (TTY), 206-685-7264 (FAX),